SCHEMBL19967537

SCHEMBL19967537

Cc1ccc(COCNC2CCCCC2)c(F)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 5/20 0.39
▸ ADRB2 P07550 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ PABPC1 P11940 1/20 0.38
▸ KMT2A Q03164 3/20 0.37
▸ GAA P10253 2/20 0.37
▸ HTT P42858 2/20 0.37
▸ MEN1 O00255 2/20 0.37
▸ TDP1 Q9NUW8 1/20 0.37
▸ NPC1 O15118 2/20 0.36
▸ RAB9A P51151 2/20 0.36
▸ CXCR3 P49682 2/20 0.36
▸ HTR2A P28223 1/20 0.36
▸ HTR2C P28335 1/20 0.36
▸ SLC6A4 P31645 1/20 0.36
▸ HDAC1 Q13547 1/20 0.36
▸ HDAC6 Q9UBN7 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ TP53 P04637 1/20 0.35
▸ CASP1 P29466 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25999947 0.81 PABPC1 (0.54) KDM4EADRB2ALDH1A1PABPC1KMT2A
SCHEMBL12204109 0.73 OPRL1 (0.50) KDM4EALDH1A1HTR2AHTR2CSLC6A4
SCHEMBL16706452 0.70 HTR1A (0.43) —
SCHEMBL16706451 0.68 IDO1 (0.38) KDM4EALDH1A1
SCHEMBL22919775 0.68 HDAC6 (0.59) KMT2AGAAHTTMEN1NPC1
SCHEMBL16663613 0.68 HDAC6 (0.59) KMT2AGAAHTTMEN1NPC1
SCHEMBL13172290 0.67 MAPK14 (0.40) —
SCHEMBL18010743 0.67 ALDH1A1 (0.49) KDM4EALDH1A1KMT2AGAANPC1
SCHEMBL13172532 0.67 IDO1 (0.37) KDM4EALDH1A1
SCHEMBL13419191 0.67 SYK (0.47) SLC6A4TP53CASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11066402-B2 3,5-disubstituted-3H-imidazo[4,5-b]pyridine and 3,5-disubstituted-3H-[1,2,3]triazolo[4,5-B] pyridine compounds as modulators of c-Met protein kinases RHIZEN PHARMACEUTICALS SA (CH) 2021-07-20 — — US disclosed
US-20180072721-A1 NOVEL 3,5-DISUBSTITUTED-3H-IMIDAZO[4,5-B]PYRIDINE AND 3,5-DISUBSTITUTED-3H-[1,2,3]TRIAZOLO[4,5-B] PYRIDINE COMPOUNDS AS MODULATORS OF C-MET PROTEIN KINASES RHIZEN PHARMACEUTICALS AG (CH) 2018-03-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180072721-A1 NOVEL 3,5-DISUBSTITUTED-3H-IMIDAZO[4,5-B]PYRIDINE AND 3,5-DISUBSTITUTED-3H-[1,2,3]TRIAZOLO[4,5-B] PYRIDINE COMPOUNDS AS MODULATORS OF C-MET PROTEIN KINASES MET, PRKCH, PRKCE KDM4E 1313/4885ADRB2 1578/4885ALDH1A1 3113/4885
US-11066402-B2 3,5-disubstituted-3H-imidazo[4,5-b]pyridine and 3,5-disubstituted-3H-[1,2,3]triazolo[4,5-B] pyridine compounds as modulators of c-Met protein kinases MET, PRKCH, HGFAC KDM4E 1448/4885ADRB2 1605/4885ALDH1A1 3018/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback